CHU Hotel Dieu

Nantes, Loire Atlantique 44000

0 studies enrolling now · 1 studies all time

What they study most

Graft Vs Host Disease, Leukemia, B-cell, Lymphoma, B-Cell, Lymphoma, Non-Hodgkin, Solid Tumor

Studies at this site

• Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib. — Running, not enrolling